MNOW Fundamental Analysis - MEDNOW INC-A

Name: MEDNOW INC-A (MNOW) Stock
Brand: MEDNOW INC-A
Rating: 0 (3 reviews)

Fundamental Rating

Overall MNOW gets a fundamental rating of 0 out of 10. We evaluated MNOW against 0 industry peers in the Unkown industry. MNOW may be in some trouble as it scores bad on both profitability and health. MNOW has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MNOW has reported negative net income.
In the past year MNOW has reported a negative cash flow from operations.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-195.36%
ROE	N/A
ROIC	N/A

ROA(3y)-65.76%

ROA(5y)-2284.76%

ROE(3y)-173.67%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MNOW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	13.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MNOW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MNOW remains at a similar level compared to 1 year ago.
Compared to 1 year ago, MNOW has a worse debt to assets ratio.

2.2 Solvency

MNOW has an Altman-Z score of -6.08. This is a bad value and indicates that MNOW is not financially healthy and even has some risk of bankruptcy.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-6.08

ROIC/WACCN/A

WACC4.05%

2.3 Liquidity

MNOW has a Current Ratio of 0.41. This is a bad value and indicates that MNOW is not financially healthy enough and could expect problems in meeting its short term obligations.
MNOW has a Quick Ratio of 0.41. This is a bad value and indicates that MNOW is not financially healthy enough and could expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.41
Quick Ratio	0.32

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MNOW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.69%.
MNOW shows a strong growth in Revenue. In the last year, the Revenue has grown by 1100.55%.

EPS 1Y (TTM)-1.69%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%26.37%

Revenue 1Y (TTM)1100.55%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%466.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MNOW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MNOW!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDNOW INC-A

TSX-V:MNOW (11/2/2023, 7:00:00 PM)

0.02

-0.04 (-63.64%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap297.29K

Revenue(TTM)35.25M

Net Income(TTM)-27.71M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.01
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.28

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-1.11

FCFYN/A

OCF(TTM)-0.96

OCFYN/A

SpS2.37

BVpS-0.13

TBVpS-0.31

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-195.36%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	13.18%
FCFM	N/A

ROA(3y)-65.76%

ROA(5y)-2284.76%

ROE(3y)-173.67%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover2.48

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	81.26%
Cap/Sales	6.34%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.41
Quick Ratio	0.32
Altman-Z	-6.08

F-Score3

WACC4.05%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1.69%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%26.37%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1100.55%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%466.23%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-8.85%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-611.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-626.99%

OCF growth 3YN/A

OCF growth 5YN/A

MEDNOW INC-A / MNOW.CA FAQ

Can you provide the ChartMill fundamental rating for MEDNOW INC-A?

ChartMill assigns a fundamental rating of 0 / 10 to MNOW.CA.

What is the valuation status for MNOW stock?

ChartMill assigns a valuation rating of 0 / 10 to MEDNOW INC-A (MNOW.CA). This can be considered as Overvalued.

What is the profitability of MNOW stock?

MEDNOW INC-A (MNOW.CA) has a profitability rating of 0 / 10.

Can you provide the financial health for MNOW stock?

The financial health rating of MEDNOW INC-A (MNOW.CA) is 0 / 10.

MEDNOW INC-A (MNOW.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MEDNOW INC-A / MNOW.CA FAQ

Can you provide the ChartMill fundamental rating for MEDNOW INC-A?

What is the valuation status for MNOW stock?

What is the profitability of MNOW stock?

Can you provide the financial health for MNOW stock?